Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1251-1258

  Li, Chuanyu ^a   Zhao, Xiangmin ^a   Toline, Eric C ^a   Siegal, Gene P ^a,b   Evans, Lynda M ^c,e   Ibrahim Hashim, Arig ^a   Desmond, Renee A ^d   Hardy, Robert W ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GUANOSINE TRIPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHORYLATION OF EXTRACELLULAR SIGNAL REGULATED KINASE; RHO FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; STEARIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW FAT DIET; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

EID: 79961184225     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr092     Document Type: Article

References (62)

1. Wickramasinghe,N.S. et al. (1996) Stearate inhibition of breast cancer cell proliferation. Am. J. Pathol., 148, 987-995.
2. Hardy,R.W. et al. (1997) Fatty acids and breast cancer cell proliferation. Adv. Exp. Med. Biol., 422, 57-69.
3. Habib,N.A. et al. (1987) Stearic acid and carcinogenesis. Br. J. Cancer, 56, 455-458.
4. Welsch,C.W. (1992) Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res., 52, 2040-2048.
5. Lui,V.W. et al. (2002) EGFR-mediated cell cycle regulation. Anticancer Res., 22, 1-11.
6. Mansour,E.G. et al. (1994) Prognostic factors in early breast carcinoma. Cancer, 74, 381-400.
7. Klijn,J.G. et al. (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrinol. Rev., 13, 3-17.
8. Threadgill,D.W. et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science, 269, 230-234.
9. Takai,Y. et al. (2001) Small GTP-binding proteins. Physiol. Rev., 81, 153-208.
10. Malaney,S. et al. (2001) The Ras signaling pathway in mammary tumorigenesis and metastasis. J. Mammary Gland Biol. Neoplasia, 6, 101-113.
11. Pruitt,K. et al. (2001) Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett., 171, 1-10.
12. Sahai,E. et al. (2001) Cross-talk between Ras and Rho signaling pathways in transformation favors proliferation and increased motility. EMBO J., 20, 755-766.
13. Spector,A.A. et al. (1969) An improved method for the addition of long chain fatty acid to protein solution. Anal. Biochem., 32, 297-302.
14. Sherr,C.J. et al. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev., 13, 1501-1512.
15. KIP1, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21CIP1/WAF1. Cell, 78, 67-74.
16. Gille,H. et al. (1999) Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem., 274, 22033-22040.
17. Suwa,H. et al. (1998) Overexpression of the RhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer, 77, 147-152.
18. Fritz,G. et al. (1999) Rho GTPases are over-expressed in human tumors. Int. J. Cancer, 81, 682-687.
19. Kamai,T. et al. (2001) Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumor. BJU Int., 87, 227-231.
20. Kleer,C.G. et al. (2002) Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol., 160, 579-584.
21. van Golen,K.L. et al. (1999) A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin. Cancer Res., 5, 2511-2519.
22. CIP1/WAF1. Nature, 394, 295-299.
23. Chan,M.M. et al. (2005) Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. Carcinogenesis, 8, 1343-1353.
24. Mu,Y.M. et al. (2001) Saturated FFAs, palmitic acid and stearic acid, induce apoptosis in human granulosa cells. Endocrinology, 142, 3590-3597.
25. Artwohl,M. et al. (2004) Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J., 18, 146-148.
26. Hardy,S. et al. (2003) Saturated fatty acid-induced apoptosis in MDAMB-231 breast cancer cells. J. Neurochem., 84, 655-668.
27. Evans,L.M. et al. (2009) Stearate preferentially induces apoptosis in human breast cancer cells. Nutr. Cancer, 61, 746-753.
28. Hunnicutt,J.W. et al. (1994) Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes, 43, 540-545.
29. Reaven,G.M. (1999) The pathological consequences of adipose tissue insulin resistance. In Reaven,G.M. and Laws,A. (eds.) Insulin Resistance, The Metabolic Syndrome X. Humana Press, Totowa, NJ, pp. 242-244.
30. CIP1/WAF1is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.
31. Hunter,T. et al. (1994) Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
32. KIP1. Genes Dev., 11, 1464-1478.
33. KIP1. EMBO J., 16, 5334-5344.
34. Khosravi-Far,R. et al. (1995) Activation of Rac1, RhoA, and mitogenactivated protein kinases is required for Ras transformation. Mol. Cell. Biol., 15, 6443-6453.
35. Qiu,R.G. et al. (1995) An essential role for Rac in Ras transformation. Nature, 374, 457-459.
36. Qiu,R.G. et al. (1997) Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell. Biol., 17, 3449-3458.
37. Bodemann,B.O. et al. (2008) GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer, 8, 133-140.
38. Narumiya,S. et al. (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev., 28, 65-76.
39. CIP1/WAF1 protein stability via a cyclin D1-impopsed block in proteasome-mediated degradation. EMBO J., 22, 2036-2046.
40. Chen,J.C. et al. (2003) Oncogenic Ras leads to Rho activation by activating the mitogen activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. J. Biol. Chem., 278, 2807-2818.
41. Wu,M. et al. (2004) RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res. Treat., 84, 3-12.
42. Kamai,T. et al. (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res., 9, 2632-2641.
43. Horiuchi,A. et al. (2003) Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest, 83, 861-870.
44. Clark,E.A. et al. (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature, 406, 532-535.
45. Kito,K. et al. (1996) Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas. Mol. Carcinog., 17, 78-83.
46. Sukumar,S. et al. (1995) Animal models for breast cancer. Mutat. Res., 333, 37-44.
47. Awad,A.B. et al. (1996) Effect of membrane lipid alteration on the growth, phospholipase C activity and G protein of HT-29 tumor cells. Prostaglandins Leukot. Essent. Fatty Acids, 55, 293-302.
48. Hanahan,D.J. (1997) Phospholipid Chemistry. Oxford University Press, New York, NY, 20-149.
49. Hardy,S. et al. (2003) Saturated fatty acid-induced apoptosis in MDAMB-231 breast cancer cells: a role for cardiolipin. J. Biol. Chem., 278, 31861-31870.
50. Evans,L.M. et al. (2009) Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice. Clin. Exp. Metastasis, 26, 415-424.
51. Griner,E.M. et al. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer, 7, 281-294.
52. Smith-Warner,S.A. et al. (2007) Fat intake and breast cancer revisited. J. Natl. Cancer Inst., 99, 418-419.
53. Boyd,N.F. et al. (1993) A meta-analysis of studies of dietary fat and breast cancer risk. Br. J. Cancer, 68, 627-636.
54. Byers,T. (1994) Nutritional risk factors for breast cancer. Cancer, 74, 288-295.
55. Hunter,D.J. et al. (1996) Cohort studies of fat intake and the risk of breast cancer-a pooled analysis. N. Engl. J. Med., 334, 356-361.
56. Boyd,N.F. et al. (2003) Dietary fat and breast cancer risk revisited: a metaanalysis of the published literature. Br. J. Cancer, 89, 1672-1685.
57. Howe,G.R. et al. (1990) Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J. Natl. Cancer Inst., 82, 561-569.
58. Saadatian-Elahi,M. et al. (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int. J. Cancer, 111, 584-591.
59. Shannon,J. et al. (2007) Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am. J. Clin. Nutr., 85, 1090-1097.
60. Wirfalt,E. et al. (2004) No relations between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal women of the Malmo Diet Cancer Cohort (Sweden). Eur. J. Clin. Nutr., 58, 761-770.
61. Singh,R.K. et al. (1995) Stearate inhibits human tumor cell invasion. Invasion Metastasis, 15, 144-155.
62. Yarden,R.I. et al. (2001) Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth. J. Cell. Biochem., 36 (suppl), 232-246.